<DOC>
	<DOCNO>NCT00034476</DOCNO>
	<brief_summary>The purpose study determine whether administration study drug effective increase chance survival patient severe sepsis . Patients enter study randomly assign one two treatment group . Patients treatment group give either study drug placebo continuous infusion directly bloodstream catheter place one patient 's vein . The study drug investigational drug still development . It study approximately 30 healthy subject , approximately 30 patient either kidney failure arthritis , approximately 600 patient severe sepsis . Patient participation study last one month .</brief_summary>
	<brief_title>A Phase IIb Study Determine Efficacy Safety Study Drug Patients With Severe Sepsis</brief_title>
	<detailed_description />
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<criteria>Patients must show evidence acute infection meet specify time windows 18 year age old Patients must low white blood cell count undergone certain organ transplant HIV positive pregnant breast feeding severe underlie medical problem</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2006</verification_date>
	<keyword>Sepsis , sPLA2 Inhibitor</keyword>
</DOC>